- US12564579utility2026Topical Formulations of (1s)-1-phenyl-2-pyridin-2-ylethanamine0 cites
- US12491246utility2025Combination Therapy of Arms and Natural Killer Cells0 cites
- US12472165utility2025Riluzole Prodrugs and Their Use0 cites
- US12383619utility2025Use of Glutamate Modulating Agents with Immunotherapies to Treat Cancer0 cites
- US12370176utility2025Methods of Use for KV7 Channel Activators0 cites
- US12364687utility2025Use of Riluzole Oral Disintegrating Tablets for Treating Diseases0 cites
- US12351559utility2025Benzoimidazol Benzomidazol-1,2-yl Amides as Kv7 Channel Activators0 cites
- US12343347utility2025Pro-drugs of Riluzole and Their Method of Use for the Treatment of Amyotrophic Lateral Sclerosis0 cites
- US12295942utility2025Riluzole Prodrugs and Their Use0 cites
- US12297206utility2025Method for Synthesizing Furoimidazopyridine Compound, Polymorphic Substance and Polymorphic Substance of Salt0 cites
- US12286408utility2025KV7 Channel Activators Compositions and Methods of Use0 cites
- US12213965utility2025Riluzole Prodrugs and Their Use0 cites
- US12201618utility2025Use of Riluzole Prodrugs to Treat Alzheimer's Disease0 cites
- US12161633utility2024Use of Riluzole Prodrugs to Treat Alzheimer's Disease0 cites
- US12121609utility2024Sublingual Formulation of Riluzole0 cites
- US12102618utility2024Use of Riluzole Prodrugs to Treat Ataxias0 cites
- US12029731utility2024Acyl Benzo[d]thiazol-2-amine and Their Methods of Use0 cites
- US12005047utility2024Riluzole Prodrugs and Their Use0 cites
- US12005046utility2024Riluzole Prodrugs and Their Use0 cites
- US11911369utility2024Prodrugs of Riluzole and Their Method of Use0 cites
Page 1 of 2Next →